l Introduction
Since the advent of medicamentous suppression of labor with beta-sympathicomimetics the calcium antagonist Verapamil** has been universally administered to antagonize cardiovascular and subjective side effects. The administration of adrenergics induces an activation of the calcium-dependent electromechanical coupling in the myocardium (Fig. 1) . The transmembranous calcium influx into the cell increases, resulting in enhanced activation of the ATP-ases. This, in turn, leads to increased consumption of high-energy phosphates, such äs ATP and creatine phosphate. Due to the accelerated heart rate and increased tension, the myocardial oxygen consumption rises. High doses of adrenergics but also protracted treatment with low doses, especially in conjunction with additional doses of Ca, vitamin D, AT 10 and cortisone äs well äs with potassium or magnesium deficiency or with heart disease may involve the risk of hypoxic necrosis development with the clinical picture of hypertrophic myocardiopathy [12] . In addition to general suppression of excitation, Verapamil antagonizes the increase of calcium influx and its consequences and thus lowers the myocardial oxygen requirement, resulting in an overall improvement of the energy balance. It is also hoped that this effect can be achieved in clinical tocolysis, in which Verapamil is administered in a maximum dose of 2 g/kg/min. A second effect, a peripheral vascular dilatation, is expected to lead to improved placental perfusion. Furthermore, amelioration of the subjective complaints associated withbeta-mimeticsisanticipated. These include tremors, heat sensations, tendency to break out in sweat, fear, and especially cardiac palpitations with their extremely unpleasant effect on the patient. The desired relaxation of the uteral muscles by the calcium antagonist, äs demonstrated in vitro, could not be clinically objectified. The efficacy of Verapamil in doses of 2 Mg/kg/min äs usual in tocolysis has not yet been established. In the numerous clinical studies only subjective 0300-5577/81/0009-0032$02.00 sensations and insensitive cardiovascular parameters of pregnant subjects could be monitored during tocolysis. A basic investigation of the desired calcium-antagonistic effect on the entire cardiovascular System including the pulmonary System is lacking. In view of the increasing immber of reports appearing in the past few years of cardiopulmonary complications, some fatal, we feel that a re-examination of the changes induced by betamimetics and their antagonization by means of the calciumantagonist Verapamil is urgent. The objective of the present work is to investigate experimentally on dogs whether Verapamil in doses of 2 Mg/kg/min has an itifluence on the effects of beta-mimetics at all. The results will be evaluated in light of prior clinical experience. A constant record was kept of the fpllowing parameters: 1. a) The pulmonary arterial pressure (PAP) and the pulmonary capillary wedge pressure (PCWP), which correlates to the left atrial pressure, by means of a 7 F $wan-Ganzthermal-dilution catheter located in the arteria pulmonalis. b) The arterial pressure by means of a fiberoptical thermistor catheter, located in the aorta ascendens (PAO)· 2. From the measured pressure parameters and the cardiac Output the total pulmonary vascular resistance (TPR) and the total systemic resistance (TSR) were derived. 3. The pressure ratios in the left ventricle were continuously monitored by means of an in* inserted microtip manometer and from the curves obtained cardiac inotropy quantities were calculated with the aid of amicroprocessor. These included maximum rate of pressure increase (dp/dt^x), maximum acceleration of pressure increase (d2p/dt 2 ), intropy Index of BRETSCHNEIDER (ING) and amultaneoudy total myocardial oxygen consumption (Er).
4. By taking blood samples the hemoglobin content (Hb), oxygen partial pressure (p0 2 ), carbon dioxide partial pressure (pC0 2 ), sodium (Na" 1 "), potassium (K*) and Chloride (Cf) concentrations, and the colloid osmotic pressure (COP) in the arterial and venous blood were determined.
5. To rule out Ventilation disturbances, a continuous evaluation of oxygen consumption (Vo 2 ) and carbon dioxide output (V CO2 ) was made.
6. Thanks to the development of the thermal dye technique it is now possible to measure accurately the fluid spaces in the lungs on a continuous basis, i.e. the intravascular and extravascular spaces [19, 22, 23, 29] .
As indicators indocyanine green and cold were used. Folio wing an injection of ice-cold indocyanine solution into the right atrium, the timeconcentration curves recorded in the aorta ascendens after passage through the lungs revealed varying mean passage times, since the dye flowed only through the intravascular space, the cold, however, through both, the intravascular and the extravascular space. From the indicator dilution curves measured in the aortic arch, the cardiac output, the extravascular flüid volüme in the lungs (EW) and the total intravascular blood volüme of the lungs (IVV) were calculated with a microprocessor.
The experimental setup described permitted a continuous appraisal of the functional parameters of the pulmonary and systemic hemodynamics, gas exchange, Metabolie changes> and fluid displacement in the lungs. It enabled us to obtain a comprehensive picture of the phärmacologicälly induced physiological processes, Statistical valuation of the effect by the üivestigated dfugs for all parameters was performed by calculating the Wilcoxontest for paired samples. Only variations compared to the base line were of interest. The level of significance was at = 0.05. The figures show the mean value and the Standard error of the mean respectively.
Results
Just shortly after infusion was commenced the following changes were observed:
The cardiac frequency increased with the administration of Fenoterol from 119/min to a maximum of 139/min (17%). The mean aortal pressure dropped from 83 mmHg to a minimum of 56 mmHg, while the pressure amplitude increased (Fig. 2) . The cardiac output rose from 116 ml/kg body weight/ min to a maximum of 158 ml/kg body weight/min. The total systemic resistance (TSR) decreased by a maximum of 44% (Fig. 3) . STROKE VOLUME dp/d The maximum rate of pressure increase rose with the administration of Fenoterol alone by a maximum of 34% and the maximum acceleration of pressure increase by a maximum of 58%. The inotropy index after BRETSCHNEIDER increased by a maximum of 67% (Fig. 4) . The total myocardial oxygen consumption (Εχ) increased similarly after administration of the beta-sympathicomimetic by a maximum of 25% (Fig. 5) . These changes were also significant and were in no way meaningfully influenced by the addition of Verapamil. The mean pulmonary arterial pressure increased under the influence of Fenoterol from 15.9 to 18.3 (15%) and reached a maximum of 19.9 mmHg with the administration of Fenoterol + Verapamil. By contrast, the pulmonary capillary wedge pressure remained constant at 8.61 mmHg throughout the entire experiment. The slight increase in total pulmonary resistance was not significant (Fig. 6) , The extravascular fluid volume in the lungs increased after just 20 minutes form 8.9 ml/kg body weight to 12.7 ml/kg body weight (42%), The fluid displacement shifted in favour of the interstice. In accordance with these findings the intravascular fluid volume decreased (Fig. 7a) . The total fluid volume remained nchanged throughout tiie experiment at an average of 22.5 ml/kg body weight (Fig. 7b) . Here too, the administration of Verapamil brought no significant iurther changes. The arterial blood gas analyses showed a drop in the oxygen partial pressure form 84.3 mmHg to 80.9 mmHg and in the oxygen Saturation from 92.7% to 87.8%, äs well äs an increase in the C0 2 -partial pressure from 37.7 mmHg to a maximum of 47.5 mmHg (Fig. 8) .
In addition, a highly significant drop in the arterial pH from 7.42 to 7.25, in the Standard bicarbonate from 23.4 mval/1 to 19.1 mval/1, and in the base excess from + 0.2 mval/1 to -7 mval/1 was observed (Fig. 9) . The changes in the venous system were even more pronounced. Here the pH showed a highly significant drop from 7.4 to 7.18, the HCOä from 27.0 mval/1 to 20.1 mval/1, and the base excess from + 2.8 mval/1 to -7.5 mval/1 (Fig. 10) . ' The venous blood gases analyses revealed a strong increase in the 0 2 partial pressure from 38.8 mmHg to 57.3 mmHg and in the venous C02 partial pressure from 45.2 mmHg to 58.1 mmHg (Fig. 11) .
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The oxygen absorption in creasedat constant respiratory volume and constant respiratory rate from 159 ml/min to 183 ml/min (15%). The CÜ2 Output increased even more strongly from 116 ml/min to 144 ml/min (24%) with a consequent increase of the respiratory quotient (RQ) from a physiological value of 0.75 to 0.83 (Fig. 12) . The other changes in the above parameters after the administration of Verapamil were not significant.
The colloid osmotic pressure in the plasma remained constant at a mean value of 18.4 mmHg. The serum potassium decreased only negligibly from 3.22 mval/1 to 2.65 mval/1, whereas the serum sodium remained unchanged at about 148 mval/1 (Fig. 13) .
With exception of the aortal pressure, which continued to drop after administration of Verapamil, none of the measured parameters was significantly further influenced by the calcium-antagonist Vera- 
Discussion
The effectiveness and the mechanism underlying the effect of the calcium antagonist Verapamil are known and are indisputable. They have been demonstrated in numerous well-founded works, in part on isolated preparations and in part on animals äs well äs on sick and healthy people [11, 15, 16, 24, 25, 26, 27] . FLECKENSTEIN [12] revealed the mechanism of the cardiotoxic effect of adrenergics and the possibility of antagonizing this effect with Verapamil (Fig. 1) . As the prototype of beti-mimetics in earlier experiments, they used Isoproterenol. It has been shown that adrenergics lead to infarct4ike lesions [33] with the clinical picture of catecholaminmyocarditis arising from hypoxiai [4, 37] . These myocardial alterations, also found after an overdose of adrenergics and in pheochromocytoma [4] , have gained importance in obstetrics ever since reports have been appearing in the past few years not only of serious pulmonary complications in the form of pulmonary edema [l, 2, 5, 8, 13, 20, 39, 43, 45, 46] , but also of severe myocardial damage in tocolysis with various beta-sympathicomimetics [2, 6, 7, 31] . Also, infantile myocardiopathy after protracted tocolysis has been observed. A cörrelation between the therapy with betä-mimetics and the cardiac damage seems at least plausible [32, 40, 42] . Thus, interest became centered on the effects of the calcium-antagonist Verapamil administered in tocolysis. Whereas at first only an improvement of the subjective complaints after administration of beta-mimetics was hoped for, it is now the question of a demonstrable effect on the cardovascular System that raises interest. The pulmonary circulatory system must be included in these considerations. The cardioprotective effect of Verapamil is associated with a negative inotropic and negative chronotropic effect. It is precisely these effects that have been least researched in tocolysis. In our experiments the contractility parameters and consequentiy also the myocardial oxygen requirement changed after administration of Fenoterol, äs is to be expected from a beta-mimetic. The contractility underwent an enormous increase äs did the oxygen consumption, the end effect of which must be a deterioration of the energy balance. The administration of Verapamil at the dosage rate of 2 Mg/kg/min had no influence on this process. Thus a cardioprotective effect on the myocardium could not be proved. That the mean arterial pressure continued to drop slightly after administration of Verapamil was chiefly due to the lowered diastolic pressure. Whether this effect is to be attributed to Feno-EXTRAVASCULAR FLUID VOLUME INTRAVASCULAR BLOOD VOLUME ml/kg KG terol or to Verapamil cannot be stated. A Verapamil effect, however, seems unlikely, in view of the fact, that no other parameter of the systemic and pulmonary drculatory System underwent furtherchange. The metabolic acidosis known to occur after administration of Fenoterol [21, 41] was also encountered in our investigations. It reacted äs little to the administration of Verapamil äs did the changes in the Ventilation and the blood gases. The explanation for the ineffectiveness of the calcium antagonist Verapamil lies in the low dose of 2 Mg/kg/min. The desired shift of the functional operating curves of the heart and the circulatory effect of Verapamil can only be achieved with doses far higher than those used in tocolysis. In these earlier studies an effect was demonstrated in dogs only after a dose of 200 Mg/kg/min, given äs a single injection, and in humans only after serum concentrations of 200 Mg/ml were reached [11, 15, 16, 24, 25] , HAAS and RASCHAK [16] also reported that in general extremely high doses of the calcium antagonist are required to obtain the negative inotropic effect. The reason for this is the rapid biotransformation of the active substance Verapamil into ineffective or only weakly effective metabolites [34] , Our own studies [38] have revealed that the average serum concentration of the mother after administration of Verapamil at a dosage rate of 2 Mg/kg/min was 19.3 ± 3 ng/ml. Since fluid displacements in the lungs up to the severity of manifest pulmonary edema after administration of adrenergics is due at least in part to hemodynamic factors [3, 10, 36] , it comes äs no surprise that the administration of Verapamil has no influence on the fluid displacement from the intravascular to the extravascular space induced by Fenoterol.
In accordance with our findings, no change in the objective cardiovascular parämeters in tocolysis with beta-mimetics attributable to the administration of Verapamil could be clinically established [14, 17, 28, 30] , The researches had restricted themselves for the most part to measuring the Parameters of the systemic circulatory System. In a recent study HOFSTETTER [18] showed the ineffectiveness of the calcium antagonist in this dosage by using echocardiography to measure the inotropy. Objective improvements in the cardiovascular load achieved with Verapamü during tocolysis that have been determined with impedance measürements [35] must be viewed with scepticism owing to the inherent errors of the method. The elimination or manifest improvement of the side effects of beta-mimetics with Verapamil described by many authors are difficult to objectify. The cardioprotectiye effect of Verapamil in a Fenoterol bath demonstrated in vitro [44] may result from the lack of metabolic decomposition and the resulting higher concentrations.
S Conclusions
1. Fenoterol at a dosage rate of 0.06 Mg/kg/min induces in dogs the cardiovascular and metabolic changes expected from the beta-sympathicomimetic. Besides this it causes significant intrapulmonary fluid shifts from the intravascular space to the interstice.
2. Verapamil in the dosage usual in clinical tocolysis of 2 g/kg/Inin has no influence on the changes induced by the beta-mimetic drug which are demonstrated in the present work. These results agree well with previous clinical experiments.
3. In order to achieve an effect the Verapamil dosage must be increased multifold, which hardly seems feasible in view of the cardiodepression and peripheral dilatation this would entail.
4. Since beta-sympathicomometics in labor suppression cannot be dispensed with at this time, further investigations will be necessary to find a substance that antagonizes the cardiovascular side effects in a way that can be objectified. 
Summary
In tocolysis with beta-sympathicomimetics Verapamil is administered universally to reduce the subjective and objective cardiovascular side effects. The efficacy of the calcium-antagonist has not yet been substantiated. This has now re-emerged s an important issue due to the increasing occurrance of cardiopulmonary complications in tocolysis, some fatal.
Nine mongrel German shepherds were anesthetized and relaxed, and their breathing was controlled at constant volume. After Infusion of Fenoterol (0.06 Mg/kg/min) and subsequent administration of Verapamil (2 Mg/kg/min) a continuous record was made of the parameters of the pulmonary and systemic circulatory Systems, the cardiac dynamics, the acid-base balance, the blood gases with O 2 absorp-tion and CO 2 Output, electrolytes and the colloid osmotic pressure. Furthermore, the intrapulmonary fluid volumes in the vascular System and the interstice were measured. During Infusion with Fenoterol the changes expected from a beta-adrenergic were observed in the form of a hyperkinetic cardiac Situation, metabolic acidosis and increased exchange of gases. Also pronounced fluid shifts in the lungs occuned from the intravascular space to the interstice. Subsequent administration of the calcium antagonist showed no influence on the beta-mimetic-induced changes demonstrated in the present work.
The results agree with previous clinical investigations. According to the known dosage curve, the dosage of Verapamil would have to be increased multifold to achieve an effect, which is hardly possible due to the cardiodepression and peripheral circulation drop with hypotension that this would entail. Resume L'administration de Verapamil, antagpniste du calcium, lors de la tocolyse par les betamimetiques, garde-t-elle encore une signification. Lors de la tocolyse par beta-mimetiques, toiit le monde administre du Verapamil afin de reduire les effets secondaires cardio-vasculaires subjectifs et objectifs. L'efficacite de cet antagoniste du calcium n'a cependant pas ete etablie. Ce point resurgit maintenant de fagon aigue a cause de la survenue croissante de complications cardio-pülmpnaires, dont quelques unes fatales, au cours de la tocolyse.
